Antimicrobial/anticancer peptides: bioactive molecules and therapeutic agents

Immunotherapy. 2021 Jun;13(8):669-684. doi: 10.2217/imt-2020-0312. Epub 2021 Apr 21.

Abstract

Antimicrobial peptides (AMPs) have been known as host-defense peptides. These cationic and amphipathic peptides are relatively short (∼5-50 L-amino acids) with molecular weight less than 10 kDa. AMPs have various roles including immunomodulatory, angiogenic and antitumor activities. Anticancer peptides (ACPs) are a main subset of AMPs as a novel therapeutic approach against tumor cells. The physicochemical properties of the ACPs influence their cell penetration, stability and efficiency of targeting. Up to now, several databases and web servers for in silico prediction of AMPs/ACPs have been established prior to the lab analysis. The present review focuses on the recent advancement about AMPs/ACPs activities including their in silico prediction by computational tools and their potential applications as therapeutic agents especially in cancer.

Keywords: anticancer peptides; antimicrobial peptides; biological activity; cancer; classification; host-defense peptides; in silico prediction; mechanisms of action; peptide antibiotics; physicochemical properties.

Publication types

  • Review

MeSH terms

  • Animals
  • Antimicrobial Peptides*
  • Humans
  • Neoplasms*

Substances

  • Antimicrobial Peptides